Solutions

PCR test systems for the diagnosis of urogenital tract infections. These reagent kits are designed for the molecular genetic identification of pathogens causing urogenital tract infections using real-time polymerase chain reaction (PCR). The line includes test systems for the detection of Chlamydia trachomatis, Ureaplasma parvum, Mycoplasma genitalium, human papillomavirus (HPV), and other clinically significant microorganisms.

PCR tests for the diagnosis of helminthiasis and protozoan invasions allow for the highly accurate detection of parasite DNA, including roundworms, flatworms, and protozoa, which is especially important when microscopic diagnostics are difficult and early detection of infection is necessary.

PCR tests for the study of the colon microbiota allow for rapid and accurate detection of changes in the composition of microorganisms, which plays a key role in the diagnosis of acute and chronic diseases, metabolic disorders and early detection of risk factors.

The IMP Target‑Check test system is designed to detect causative agents of urinary tract infections and to identify nucleotide sequences (resistance genes) that determine bacterial resistance to polymyxin, beta-lactam, glycopeptide, and fluoroquinolone antibiotics.

The Dermatophytosis‑PCR reagent kit is designed for the detection of DNA from fungi of the genera Trichophyton, Microsporum, and Epidermophyton, which cause infections of the skin, hair, and nails. The kit allows for the detection of the pathogens' DNA and the determination of the presence of genes conferring resistance to terbinafine.

PCR kits for veterinary diagnostics allow for the rapid and accurate detection of DNA and RNA of pathogens causing viral, bacterial and parasitic diseases in animals, ensuring reliable monitoring of the health of domestic and farm animals.

Alphalab offers development and production of individual PCR test systems, allowing to create a solution for any diagnostic task with high accuracy, sensitivity and efficiency of analysis in real time.